BAILLIE GIFFORD & CO 13D and 13G filings for Moderna, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-04-30 06:47 am Sale | 2025-03-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 24,948,558 6.500% | -13,941,013 (-35.85%) | Filing |
| 2025-02-12 09:07 am Sale | 2024-12-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 38,889,571 10.100% | -6,764,956 (-14.82%) | Filing |
| 2024-01-29 10:49 am Purchase | 2023-12-29 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 45,654,527 11.970% | 867,781 (+1.94%) | Filing |
| 2023-01-19 11:25 am Sale | 2022-12-30 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 44,786,746 11.660% | -985,333 (-2.15%) | Filing |
| 2022-01-26 10:26 am Purchase | 2021-12-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 45,772,079 11.290% | 1,080,693 (+2.42%) | Filing |
| 2021-03-01 11:26 am Purchase | 2021-02-26 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 44,691,386 11.180% | 20,379,115 (+83.82%) | Filing |
| 2021-01-27 11:28 am Purchase | 2020-12-31 | 13G | Moderna, Inc. MRNA | BAILLIE GIFFORD & CO | 24,312,271 6.140% | 24,312,271 (New Position) | Filing |